http://www.fresenius.com en-us Wed, 20 Nov 2019 00:00:00 +0100 Wed, 20 Nov 2019 00:00:00 +0100 Wed, 20 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care places bonds with a volume of 1.75 billion euros]]> Fresenius Medical Care today successfully placed bonds in three tranches with an aggregate volume of €1.75 billion.

]]>
Tue, 12 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Vamed completes main university hospital building in Lübeck ]]> After four years of construction Fresenius Vamed has completed the new main building at University Hospital Schleswig-Holstein (UKSH) in Lübeck. Following the opening in August of the new main building at the UKSH’s other location, in Kiel, the modernization of Germany’s second-largest university hospital is now largely complete. In addition to the new construction and the comprehensive renovation of the two university hospital locations, the project includes their technical management through 2044. With a total volume of €1.7 billion, the UKSH modernization is currently the biggest public-private partnership project in Europe’s healthcare sector.

]]>
Tue, 05 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Vamed wins awards for spa and wellness facilities]]> VAMED Vitality World has been named the “World’s Best Thermal Spa & Medical Wellness Operator 2019” at the World Spa Awards. Four VAMED Vitality World facilities – Geinberg5 Private Spa Villas, St. Martins Therme & Lodge, Therme Laa Hotel & Spa and la pura women’s health resort – also won in their individual categories. VAMED Vitality World, part of Fresenius Vamed, operates a total of nine spa and health resorts in Austria.

]]>
Mon, 04 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care launches connected health platform in North America]]> Fresenius Medical Care North America (FMCNA) has launched its new connected health platform called TheHub. The platform is comprised of three integrated applications - PatientHub, CareTeamHub and ProviderHub - that enable patients, care teams, and providers to better collaborate and monitor patient treatments. Research by FMCNA indicates that patients who actively use these connected health solutions have a 20 percent lower risk of hospitalization, higher transplantation rates, and stay on the modality longer.

]]>
Mon, 04 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Helios acquires medical diagnostics provider in Colombia]]> Quirónsalud, Spain’s largest private hospital group and part of Fresenius Helios, has acquired CediMed, a leading medical diagnostics group in Colombia. CediMed operates seven centrally located centers in Medellin.

]]>
Fri, 01 Nov 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care North America achieves strongest quality ratings to date]]> Fresenius Medical Care North America continues to improve clinical quality as measured by the U.S. government’s Five-Star Rating System. More than 94 percent of the company’s dialysis centers were rated three stars and above for clinical quality, with a total of 762 centers achieving the highest five star rating, up from 658 last year. The Centers for Medicare and Medicaid Services (CMS) assigns one to five stars to each dialysis center annually based on a series of measurements around clinical performance and patient outcomes.

]]>
Tue, 29 Oct 2019 08:00:00 +0100 <![CDATA[Fresenius confirms guidance after solid third quarter]]> Stephan Sturm, CEO of Fresenius, said: “Our businesses developed solidly in the third quarter, keeping Fresenius on track to deliver the results that we promised earlier this year. We posted strong organic growth across all four business segments. Our investments in future growth are proceeding as planned. (...)"

]]>
Tue, 29 Oct 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care appoints Dr. Frank Maddux to Management Board, makes Global Chief Medical Officer a board position]]> Fresenius Medical Care, the world’s leading provider of dialysis products and services, announced today the appointment of Dr. Frank Maddux, 61, the company’s Global Chief Medical Officer, to the Management Board. He will start in his new position on January 1, 2020.

]]>
Tue, 29 Oct 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care again delivers strong organic growth in the third quarter]]> Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: “In the third quarter Fresenius Medical Care once again achieved stable, healthy growth. Our underlying business continues to develop according to plan and we are working successfully to provide even more patients with ever better and more individualized treatment options. (...)"

]]>
Wed, 23 Oct 2019 08:00:00 +0100 <![CDATA[Fresenius Kabi expands plant in Brazil]]> Fresenius Kabi has completed the expansion of its plant in Aquiraz, Brazil, increasing the facility’s capacity for parenteral nutrition production by around 30 percent. The company expects to hire about 50 new employees to bring the plant’s workforce to about 850. Fresenius Kabi, which has been active in Brazil for more than 40 years, invested some €20 million in the expansion and modernization of the Aquiraz plant.

]]>
Wed, 16 Oct 2019 08:00:00 +0100 <![CDATA[Fresenius celebrates expansion of Bad Homburg headquarters]]> The healthcare group Fresenius has nearly completed the work begun two years ago to expand company headquarters in Bad Homburg. Two new office buildings; “EK3” at Else-Kröner Street and “D15A” located at Daimler Street have been in operation since April.

]]>
Wed, 18 Sep 2019 08:00:00 +0100 <![CDATA[Fresenius Helios develops system to measure patient safety]]> Fresenius Helios has developed a new system for measuring patient safety, and is introducing it in all 86 Helios hospitals across Germany. The new system will complement the company’s existing quality management system and combine internationally established patient safety indicators with various indicators that Helios has developed through clinical practice. These include measurements on such indicators as false diagnoses, medication errors and patient falls. When Helios begins reporting the results next year, it will be the first German hospital operator to provide patient safety data that can be compared internationally.

]]>
Wed, 18 Sep 2019 08:00:00 +0100 <![CDATA[Fresenius Kabi opens research and development center for biosimilars in Switzerland]]> Fresenius Kabi has opened a new research and development center for biosimilars in Eysins, in the Swiss canton of Vaud. The facility, in which the company invested about €15 million, will strengthen Fresenius Kabi’s capability to develop new biosimilars, particularly in the areas of autoimmune diseases and oncology. A biosimilar is a drug that is “similar” to another, already approved biologic drug. More than 100 employees representing over 20 nationalities work at the Eysins site, and the company plans to expand the workforce in the near future.

]]>
Tue, 17 Sep 2019 08:00:00 +0100 <![CDATA[Fresenius SE & Co. KGaA included in Dow Jones Sustainability Index]]> Fresenius will be included in the Dow Jones Sustainability Index Europe (DJSI Europe) for the first time as from 23 September 2019. The selected companies must demonstrate continuous improvement with regard to sustainability and are assessed by analysts from asset manager RobecoSAM.

]]>
Mon, 16 Sep 2019 08:00:00 +0100 <![CDATA[2020 DRG inflator for German hospitals set at 3.66%]]> The price increase for hospital services in Germany has been set at 3.66% for 2020. As it is subject to negotiations at the state level as well as individual hospital discounts, the final price increase on the individual hospital level will, however, be lower.

]]>
Wed, 11 Sep 2019 08:00:00 +0100 <![CDATA[Fresenius Helios launches digital portal for patients]]> Fresenius Helios patients in Germany can soon start accessing letters from their doctors, test results and other medical documents over an online platform – the Helios Patients Portal. This new portal can also be used to make appointments. The confidentiality of patient data is assured through the use of two-factor authentification. All 86 of the company’s hospitals, 126 medical care centers and eight prevention centers throughout Germany are being gradually linked to the Helios Patients Portal. The company is also developing a portal for doctors.

]]>
Mon, 09 Sep 2019 08:00:00 +0100 <![CDATA[Global Insights and Local Promise: Fresenius Medical Care’s annual medical report explores how Interconnected Intelligence is transforming healthcare]]> Fresenius Medical Care today announced the publication of its 2019 global annual medical report. Titled “Global Insights, Local Promise: Transforming Healthcare Through Interconnected Intelligence,” it outlines how the company is harnessing the power of an increasingly interconnected world to pioneer solutions that can have a large-scale impact on patient care.

]]>
Fri, 06 Sep 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care builds new laboratory in Mississippi]]> Spectra Laboratories, a wholly-owned subsidiary of Fresenius Medical Care North America, broke ground on a 200,000-square-foot (approx. 18,500 square meters) laboratory in Southaven, Mississippi yesterday. The project is expected to create more than 300 jobs over the next three years. Spectra Laboratories offers renal-specific laboratory services, using state-of-the-art equipment, automated specimen processing, and reporting applications. At Spectra’s new build-to-suit facility, employees will conduct comprehensive testing, analysis, and reporting to ensure the best possible outcomes for patients.

]]>
Thu, 05 Sep 2019 08:00:00 +0100 <![CDATA[Fresenius Medical Care invests EUR 60 million in Unicyte]]> Fresenius Medical Care plans to invest EUR 60 million in its independent affiliate Unicyte AG in a Series A financing round. Unicyte will primarily use the capital to start clinical trials of its first product candidates in 2020 and to establish the required manufacturing processes.

]]>
Mon, 02 Sep 2019 08:00:00 +0100 <![CDATA[Fresenius Helios acquires two hospitals in Colombia]]> Quirónsalud has acquired Clínica Las Vegas and Clínica del Prado and further expanded its presence in the attractive private hospital market in Colombia. Clínica Las Vegas and Clínica del Prado are two centrally located hospitals in Medellín, a major city of 2.5 million people.

]]>